Gene and cell therapy analytical and development methods: A path to success
In the decades that have passed since the approval of the first gene therapy in 1990, these revolutionary medicines have changed the lives of patients all over the world.
Process development and analytical development are integral parts of gene therapy manufacturing. Choosing the right methods will enhance the safety, quality, and efficacy of the final product, and enable smooth, rapid delivery from preclinical to commercial.
But this is not without hurdles, particularly in this relatively new therapeutic space.
This whitepaper explores the analytical and development approaches needed to create a path to success in the clinic and beyond.
You can download the full white paper by completing the form below.